Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling pathway.

Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
Shiyun ShaoYan Wang

Abstract

Depressive symptoms are thought to promote cancer development and depressive remission has been reported to be effective for defeating cancer. The herbal formula Xiao-Chai-Hu-Tang (XCHT), that has an anti-depressive efficacy, has been widely utilized in China. However, its anti-cancer effect and underlying mechanisms remain unclear. The present study aims to investigate the effects of XCHT on the depression-associated tumor and its potential mechanisms. A placebo-controlled trial was conducted in cancer patients comorbid with depressive symptoms to evaluate the effects of XCHT on depressive scales, tumor-related immune indicators, and gut microbial composition. A xenografted colorectal cancer (CRC) mouse model exposure to chronic restraint stress (CRS) was established to examine XCHT effects on tumorigenesis in vivo. Further, by manipulating gut bacteria with fecal microbial transplantation (FMT) or antibiotics-induced bacterial elimination in CRS-associated xenografted model, gut microbiota-mediated anti-tumor mechanism was explored. In cancer patients comorbid with depressive symptoms, XCHT showed substantial effects on improvement of depressive scales, system inflammatory levels and gut dysbiosis. In vivo, XCHT inhibited tum...Continue Reading

References

Aug 2, 2003·Biological Psychiatry·David Spiegel, Janine Giese-Davis
Jun 6, 2007·The Lancet Oncology·Martin R StocklerUNKNOWN Zoloft's Effects on Symptoms and survival Time Trial Group
Feb 23, 2008·General Hospital Psychiatry·Jesse R FannJulie Gralow
Aug 5, 2009·The American Journal of Psychiatry·Robert M Post
Feb 7, 2013·Trends in Neurosciences·Jane A Foster, Karen-Anne McVey Neufeld
Dec 18, 2013·Nature·Lawrence A DavidPeter J Turnbaugh
Jul 12, 2016·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Zhili XiongChunfu Wu
Sep 11, 2017·Brain, Behavior, and Immunity·Julieta SchachterJohn D Young
Apr 18, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Francesca Romana PonzianiVincenzo Mazzaferro
May 31, 2018·International Journal of Molecular Sciences·Shan LiangFeng Jin
Jul 11, 2018·Nature Protocols·Meng-Ying LiuQi-Gang Zhou
Feb 6, 2019·Nature Microbiology·Mireia Valles-ColomerJeroen Raes
Feb 17, 2019·Brain, Behavior, and Immunity·Timothy G Dinan, John F Cryan
Feb 25, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hui-Zheng ZhuJia-Xu Chen
May 22, 2019·Brain, Behavior, and Immunity·Nathalie MichelsJames Keane
Jul 18, 2019·Immunity·Florian R Greten, Sergei I Grivennikov
Sep 12, 2019·Annual Review of Pharmacology and Toxicology·Caitríona Long-SmithJohn F Cryan
Sep 27, 2019·Nature Reviews. Gastroenterology & Hepatology·Sunny H Wong, Jun Yu
Oct 1, 2019·Annual Review of Psychology·Joana S Cruz-PereiraJohn F Cryan
Oct 9, 2019·Cell Death & Disease·Wonbeak YooSeokho Kim
Jan 3, 2020·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Liandi ChiYing Zheng
Feb 23, 2020·Life Sciences·Luiz Antonio LupiLuiz Gustavo de Almeida Chuffa
May 1, 2020·International Journal of Cancer. Journal International Du Cancer·Michaela LangChristoph Gasche
Jun 10, 2020·Journal of Neuroinflammation·Ao-Qi SongWen-Ning Wu
Aug 1, 2020·Immunity·Chunliang XuPaul S Frenette
Oct 29, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zhaozhou ZhangYan Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.